Ginger Menstrual Pain Randomized Trial: What the Evidence Says

Quick Answer

Ginger Menstrual Pain Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 systematic review, 1 research article.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Statistically significant reductions in pain severity, improved cognitive function, and gastrointestinal symptoms were observed. [Lagzian Y (2025); evidence level 1]
• Background Various aspects of women's functioning are affected by menstrual disorders. [Lagzian Y (2025); evidence level 1]
• These therapies lack the drawbacks associated with traditional symptomatic medications, such as non-steroidal anti-inflammatory drugs (NSAIDs) and oral contraceptives, which can increase the risk of adverse effects like mild neurological symptoms (headaches, drowsiness, dizziness) and gastrointestinal symptoms (nausea, indigestion). [Ma W (2026); evidence level 4]
• Complementary and alternative medicine (CAM) has been used for the treatment of primary dysmenorrhea for centuries. [Ma W (2026); evidence level 4]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For ginger menstrual pain randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Lagzian Y (2025). The Effects of Peppermint on Menstrual Disorders: A Systematic Review of Randomized Controlled Trials.. DOI: 10.4103/ijnmr.ijnmr28323. PMCID: PMC12655842. PMID: 41311590. https://pmc.ncbi.nlm.nih.gov/articles/PMC12655842/
• Ma W (2026). Complementary and alternative therapies in the treatment of primary dysmenorrhea.. DOI: 10.3389/frph.2025.1730164. PMCID: PMC12835285. PMID: 41608300. https://pmc.ncbi.nlm.nih.gov/articles/PMC12835285/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.